Vitrolife AB (publ)
VTRLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $88 | $871 | $842 | $959 |
| % Growth | -89.9% | 3.4% | -12.2% | – |
| Cost of Goods Sold | $43 | $366 | $359 | $373 |
| Gross Profit | $45 | $505 | $483 | $586 |
| % Margin | 51% | 58% | 57.4% | 61.1% |
| R&D Expenses | $2 | $29 | $26 | $28 |
| G&A Expenses | $0 | $130 | $115 | $142 |
| SG&A Expenses | $26 | $333 | $298 | $341 |
| Sales & Mktg Exp. | $0 | $203 | $183 | $199 |
| Other Operating Expenses | $0 | $6 | $8 | -$8 |
| Operating Expenses | $28 | $368 | $332 | $361 |
| Operating Income | $16 | $137 | $151 | $225 |
| % Margin | 18.6% | 15.7% | 17.9% | 23.5% |
| Other Income/Exp. Net | -$3 | -$5 | -$11 | -$42 |
| Pre-Tax Income | $14 | $132 | $140 | $183 |
| Tax Expense | $3 | $32 | $41 | $43 |
| Net Income | $11 | $100 | $100 | $139 |
| % Margin | 12.2% | 11.5% | 11.9% | 14.5% |
| EPS | 0.079 | 0.74 | 0.74 | 1.03 |
| % Growth | -89.3% | 0% | -28.2% | – |
| EPS Diluted | 0.079 | 0.74 | 0.74 | 1.02 |
| Weighted Avg Shares Out | 135 | 135 | 135 | 135 |
| Weighted Avg Shares Out Dil | 135 | 135 | 135 | 136 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $5 | $10 | $43 |
| Depreciation & Amortization | $12 | $0 | $0 | $46 |
| EBITDA | $27 | $137 | $150 | $271 |
| % Margin | 30.5% | 15.7% | 17.8% | 28.3% |